Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
61 /100
HIGH RISK
Score updated Oct 13, 2026

TENX — Tenax Therapeutics, Inc. Dilution Risk Tracker

Track TENX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TENX — Get alerts when the score changes →

As of October 13, 2026, Tenax Therapeutics, Inc. (TENX) has a DilutionWatch DilutionScore of 61/100, rated HIGH dilution risk. Tenax Therapeutics, Inc. has a market capitalization of $62.87M, 37.42M shares outstanding, 80 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $300.00M, 7.51M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
0
📊 Float Risk
90
⚠️ Warrant Exposure
70
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 36%
📜 Warrant Exercise model 40%
• Significant warrants: 20% of shares outstanding
• Elevated warrant risk score (70/100)
🔁 Convertible Conversion model 40%
• Significant convertible debt: 21% potential dilution
• Elevated convertible risk (60/100)
💰 Capital Raise model 20%
• Active shelf registration ($300M, 477% of market cap)
🔔 Track TENX — Get forecast alerts →

Market Data

Market Cap$62.87M
Shares Outstanding37.42M
Float10.61M
Cash$118.00M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore61/100DilutionWatch score record
Shares Outstanding37.42MVerified float table or market cache
Public Float10.61MVerified float table or market cache
Market Cap$62.87MMarket data cache
Cash Runway61.1 monthsDilutionWatch score inputs
Shelf Capacity$300.00MSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants7.51MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 3, EFFECT 1, S-3 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 280.7% shares (2026Q1 vs prior)
80 institutional holders · 26.70M shares
#1 JANUS HENDERSON GROUP PLC 3.63M shares
#2 PRICE T ROWE ASSOCIATES INC /MD/ 2.95M shares
#3 PERCEPTIVE ADVISORS LLC 2.90M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.18M
Days to Cover2.4
% of Float67.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-07-31
xbrl XBRL CONVERTIBLE 2026-03-10
EFFECT EFFECT 2026-04-01
S-3 SHELF 2026-03-24
4 INSIDER TRANSACTION 2026-02-03
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TENX Dilution Snapshot

Tenax Therapeutics, Inc. (TENX) has a DilutionScore of 61/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TENX's DilutionScore is currently 61/100 (High risk), with 6 score changes tracked over 89 days. The score improved from 52/100 (High risk).

Period Score Risk Level Duration
Oct 11 – Oct 13, 202661/100HIGH3 days
Oct 01 – Oct 10, 202652/100HIGH10 days
Sep 27 – Sep 30, 202655/100HIGH4 days
Aug 22 – Sep 26, 202654/100HIGH36 days
Aug 14 – Aug 21, 202648/100MEDIUM7 days
Jul 17 – Aug 13, 202650/100MEDIUM28 days
Jul 16, 202649/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TENX shares outstanding have increased 2.9% from 25.78M (May 2026) to 26.53M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 15, 202626.53M10.61M▼ 51.74%
May 01, 202625.78M21.99M▲ 28.12%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TENX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TENX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TENX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TENX
TENX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.